Cargando…
m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis
BACKGROUND: Pulmonary fibrosis is difficult to treat. Early diagnosis and finding potential drug therapy targets of pulmonary fibrosis are particularly important. There were still various problems with existing pulmonary fibrosis markers, so it is particularly important to find new biomarkers and dr...
Autores principales: | Deng, Meng-Sheng, Chen, Kui-Jun, zhang, Dong-Dong, Li, Guan-Hua, Weng, Chang-Mei, Wang, Jian-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050297/ https://www.ncbi.nlm.nih.gov/pubmed/35497924 http://dx.doi.org/10.1155/2022/2425065 |
Ejemplares similares
-
Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis
por: Weng, Chang-Mei, et al.
Publicado: (2020) -
m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease
por: Huang, Xinwei, et al.
Publicado: (2020) -
LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation
por: Wang, Xiaoying, et al.
Publicado: (2022) -
Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022) -
Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)